Aleksandra Nikolić1,2
Darko Boljević2*Milovan Bojić1,2Stefan Veljković2Dragana Vuković3Bianca Paglietti4Jelena Micić5Salvatore Rubino4- 1Faculty of Medicine, University of Belgrade, Belgrade, Serbia
- 2“Dedinje” Cardiovascular Institute, Belgrade, Serbia
- 3Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
- 4Department of Biomedical Sciences, University of Sassari, Sassari, Italy
- 5Clinic for Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade, Serbia
Lyme endocarditis is extremely rare manifestation of Lyme disease. The clinical manifestations of Lyme endocarditis are non-specific and can be very challenging diagnosis to make when it is the only manifestation of the disease. Until now, only a few cases where reported. Physicians should keep in mind the possibility of borrelial etiology of endocarditis in endemic areas. Appropriate valve tissue sample should be sent for histopathology, culture, and PCR especially in case of endocarditis of unknown origin PCR on heart valve samples is recommended. With more frequent PCR, Borrelia spp. may be increasingly found as a cause of infective endocarditis. Prompt diagnosis and treatment of Lyme carditis may prevent surgical treatment and pacemaker implantations. Due to climate change and global warming Lyme disease is a growing problem. Rising number of Lyme disease cases we can expect and rising number of Lyme endocarditis.
Lyme Endocarditis Highlights
– Lyme endocarditis is a rare manifestation of Lyme disease
– Manifestations of Lyme endocarditis are non-specific, and diagnosis can be challenging
– In case of endocarditis of unknown origin, Polymerase Chain Reaction (PCR) of heart valve samples is recommended
– If routine analyses do not reveal a pathogen agent, the physician should think about Lyme endocarditis
– When a cardiac surgeon, during surgery, suspects infective endocarditis, a tissue sample should be taken for histopathology, culture, and PCR
– Prompt diagnosis and treatment of Lyme carditis may avoid surgical treatment and pacemaker implantation
– Due to climate change, we can expect more cases of Lyme carditis with involvement of heart valve
Introduction
Almost 45 years after its first recognition, Lyme disease (LD) has recently become a huge and growing problem, both in Europe and the United States (Lindgren and Jaenson, 2006). Due to global climate changes, LD is emerging as a threat to public health, easy spreading rapidly into new territories with a lack of a prevention method. The vector that carries the infective agent can be found in places where it has never been found before (Estrada-Peña et al., 2018), and these tick distribution and density changes have been shown to be related to changes in climate (Liang and Gong, 2017). If it is not immediately recognized and treated, it can be a life-threatening disease with multiple cardiac and neurological manifestations (Kannangara et al., 2019).
Lyme carditis (LC) is a rare manifestation of LD that includes: heart conduction abnormalities, myocarditis, pericarditis, endocarditis, pancarditis, arrhythmias, dilatative cardiomyopathy and congestive heart failure, myocardial infarction, and coronary aneurysms (Hidri et al., 2012; Kostić et al., 2017). Lyme endocarditis (LE), one possible manifestation of LC, is rare and has been the subject of case reports. Due to climate change, an increased incidence rate of LC with involvement of heart valve can be expected (Lindgren and Jaenson, 2006; Liang and Gong, 2017; Estrada-Peña et al., 2018; Kannangara et al., 2019).
Epidemiology
Lyme disease is endemic and the most common vector-borne bacterial disease transmitted to humans in North America, Europe, and Asia. In the United States, around 60,000 cases were reported in 2017, according to the Centers for Disease Control and Prevention (CDC), an increase of more than 20% over 2016 (Centers for Disease Control and Prevention [CDC], 2018). In 2015, LD was the sixth most common nationally notifiable disease in the United States. In the states where LD is most common, the average incidence is 39.5 cases per 100,000 persons (Northeast, mid-Atlantic, and upper Midwest of the United States) (Bacon et al., 2008). It seems that this number is underestimated and that the actual incidence of LD could be as much as 10 times higher than the CDC data indicate. This is a result of inadequate reporting, misdiagnosis, and the fact that physicians tend to underreport reportable diseases (Adams et al., 2015).
Estimation from available national data suggests that there are about 85,000 cases per year in Europe where most LD is reported by Scandinavian countries, Germany, Austria, and Slovenia (Lindgren and Jaenson, 2006). Smith and Takkinen (2006) showed that the estimated incidence of LD was as high as 206 cases per 100,000 population in Slovenia and 135 cases per 100,000 population in Austria, which are among the highest reported rates in Europe. Increases in prevalence have also been observed in Sweden, Germany, Czechia, Norway, and Finland (Jaenson and Lindgren, 2011; Heinz et al., 2015; Semenza and Suk, 2017). In Asia, Borrelia burgdorferi infection has been reported in countries including China, Korea, Japan, Indonesia, and Nepal and in eastern Turkey (Jaenson and Lindgren, 2011; Heinz et al., 2015). Beside the above-mentioned areas, cases were reported in more tropical locales, and LD may exist in Australia (Dehhaghi et al., 2019).
Cardiac Manifestation of Lyme Disease and Valve Involvement
Lyme carditis is rare, representing only 0.3–4% of cases in Europe (Hidri et al., 2012). In the United States, between 4 and 10% of patients who do not undergo treatment of LD develop carditis (Paim et al., 2018). LC is associated with acute-onset atrioventricular blocks (I–III), which are the most common feature of LC, arrhythmias and myocarditis or pericarditis, and pericardial effusion, while the chronic stage includes dilated cardiomyopathy (Palecek et al., 2010; Hidri et al., 2012). In a review of 84 patients who had LC, 69% reported palpitations, 19% had conduction abnormalities, 10% had myocarditis, and 5% had left ventricular systolic dysfunction (Paim et al., 2018).
Valvular involvement, as a manifestation of LC, is extremely rare and is the subject of case reports (Hidri et al., 2012; Paim et al., 2018). To date, seven cases in the adult population have been reported and one in the pediatric population. It is important to know that complete conduction recovery with antibiotic treatment occurs in more than 90% of LC cases (Kostić et al., 2017). In areas where LD is endemic, the evaluation of acute-onset cardiac symptoms, with evidence of conduction disease or valvular pathology, should lead to a work-up for LC (Palecek et al., 2010; Kostić et al., 2017; Paim et al., 2018). Prompt diagnosis and treatment of LC may prevent unnecessary surgical treatment, pacemaker implantation, or treatment of heart failure (Palecek et al., 2010; Hidri et al., 2012; Paim et al., 2018).
Pathoimmunology
Borrelia burgdorferi is a highly invasive spirochete that produces adhesions. Via these proteins, B. burgdorferi adheres to endothelial cells and to components of the extracellular matrix. By changing of its surface, B. burgdorferi modifies immunological response and decreases the phogocytosis of the infected organism (Zajkowska et al., 2000; Zajkowska and Hermanowska–Szpakowicz, 2002; Raveche et al., 2005). Wasiluk et al., in their paper, stated that, in resistant chronic LD, autoimmune mechanisms play a role in persistent disease (Wasiluk et al., 2011). B. burgdorferi displays tropism to heart connective tissue, synovial membrane, ligaments, tendon attachments, and vascular endothelium, where it makes molecular changes (dominantly in Lyme arthritis and LD) (Froude et al., 1989; Grzesik et al., 2004; Raveche et al., 2005; Petzke and Schwartz, 2015). There is a belief that autoimmunity and genetic predisposition may play important roles in the inflammation process. One of the mechanisms of autoimmunity is molecular mimicry. By aggregation with fibroblasts and tissue proteins, B. burgdorferi disturbs the secretion of cytokines and antibodies, but it can directly attack and destroy T and B lymphocytes as well (Zajkowska et al., 2000; Raveche et al., 2005). This spirochete activates chemotactic factors by induction of interleukins (IL) IL1, IL6, IL8, and IL10, mediators of inflammation, and immunological complexes and activates the complement system (Steere et al., 2001; Tuchocka, 2002; Raveche et al., 2005; Wasiluk et al., 2011).
Lyme Endocarditis: a Review of the Literature
A computerized literature search was conducted using the PubMed databases for relevant articles on LE published in English from 1977 to July of 2019. A possible connection between LD and valve involvement in a 56-year-old male was described in 1993 by Anish. The diagnosis was based on clinical findings: aortic valvular vegetation revealed by transesophageal echocardiography, positive Borrelia spp. serology, and prompt improvement after ceftriaxone therapy. However, neither histopathologic nor molecular screening of valvular tissue was performed in order to confirm the suspicions of LE (Anish, 1993). Canver et al. described a case of fulminant LE with involvement of mitral valve in a B. burgdorferi seropositive patient, but again, without valve tissue analysis for confirmation (Canver et al., 2000). Borrelia bissettii was detected in the aortic valve tissue of a patient with endocarditis and aortic stenosis in the Czechia. Molecular analysis of a valve sample confirmed the presence of B. bissettii DNA (Rudenko et al., 2008).
Hidri et al. (2012) described the first case of Borrelia afzelii LE, in a 61-year-old man living in an endemic area of France. They reported a case of endocarditis of mitral valve. The diagnosis was confirmed by detection of B. afzelii DNA by specific real-time Polymerase Chain Reaction (PCR). The patient was scheduled for mitral valve replacement due to mitral regurgitation caused by mitral valve prolapse and rope rupture. During surgery, the macroscopic analysis of the mitral valve, showing prolapse of the posterior and perforation of the anterior valve, suggested endocarditis. All routinely performed microbiological analysis was negative, but microscopic analysis revealed intracellular microorganisms that were ultimately confirmed as B. afzelii. This case emphasized the need to perform PCR on heart valve samples in the case of endocarditis of unknown origin and to have in mind the possibility of borrelial etiology in endemic areas.
The first case of LE confirmed by molecular diagnostics in the United States was reported by Paim et al. (2018) in a 68-year-old male who presented with heart failure with suspected community-acquired pneumonia. Transesophageal echocardiogram revealed severe mitral regurgitation due to aneurismal dilatation of the anterior mitral leaflet with a perforation. These findings suggested infectious etiology. The patient reported LD 8 years previously, which was treated with two sequential courses of doxycycline. The results of serological testing were negative, including four blood cultures as well as virus testing and PCR of Tropheryma whippelii and Borrelia spp. Results of the 16S rRNA PCR and sequencing performed on resected mitral valve tissue were positive for B. burgdorferi. Diagnosis of LE can be very challenging due to an inability to grow the organism in culture, and serologic testing cannot distinguish current from prior infection, especially when it is the only manifestation of the disease (Paim et al., 2018).
Authors from Cleveland reported a case of LE confirmed by PCR without prior clinical manifestations of LD. They described a case of a 65-year-old female with mitral regurgitation due to myxomatous mitral valve degeneration and valve prolapse who underwent mitral valve repair. She denied tick bites or annular rash. During the operation, the surgeon suspected an infective rather than degenerative etiology due to anterior leaflet scarring and destruction over the A2 area, with thickened chords. All tissue cultures were negative. DNA of B. burgdorferi was identified by 16S ribosomal ribonucleic acid sequencing. This case suggests that when the cardiac surgeon suspects on infective pathology, tissue samples should be sent for culture, histopathology, and PCR analysis (Haddad et al., 2019).
Cardiac manifestations of LD typically include the atrioventricular conduction system, rarely heart valves. Patel and Schachne (2017) reported a case of a 59-year-old male with involvement of both the electrical conduction system and the mitral valve. LD was diagnosed on the basis of elevated immunoglobulins IgA, IgM, and IgG to B. burgdorferi. The authors revealed that mitral regurgitation was likely to be chronic rather than acute due to the echo parameters. Complete recovery of the conduction system after antibiotic treatment was noticed in this case, and stress echocardiography showed reduced mitral regurgitation. Their conclusion was that local invasion of pathogen and macrophage caused leaflet edema. Histopathology was not done, and they speculated whether it was possible that local myocardial inflammation had worsened the regurgitation of a chronically diseased valve. Finally, in areas endemic for LD, the evaluation of acute-onset cardiac symptoms, especially with evidence of conduction disease or valvular pathology, physicians should think of LC and LE. Prompt diagnosis and treatment of LD and LE may prevent surgical treatment and pacemaker implantation (Patel and Schachne, 2017).
The only LD case in children with suspected involvement of mitral valve was reported by Kameda et al. (2012) They described an unusual manifestation of LD in a 7-year-old girl with Lyme neuroborreliosis with meningoradiculitis and involvement of mitral valve that was discovered due to a heart murmur. She was treated by cefotaxime for 4 weeks. After one year, echo showed a normal mitral valve with trivial mitral regurgitation. In children, LE is extremely rare, and this is the only case in the literature with suspected valve involvement in a child. Despite improvement after therapy, there was no evidence from histopathology or PCR of the valve tissue and no definitive diagnosis of LE (Kameda et al., 2012). A summary of the case reports is given in Table 1.
Table 1. Summary of Case Reports of Lyme Endocarditis.
Lyme endocarditis is a rare condition, but new cases can be expected due to climate change. Global warming, as one of the components of climate change, has increased significantly in recent years, and it has had a huge impact on human health (Watts et al., 2015). The effect of global warming on human health is divided into two categories: a direct effect on disease, such as heat shock and increased mortality in the population with other diseases, and an indirect effect on diseases such as infectious diseases and allergies. Heatwaves, storms, drought, and floods result in a shift in the distribution of pathogens and vectors, which consequently results in a shift in the distribution of human infectious disease (Kuhn et al., 2005; Tian et al., 2015).
Tick-born disease and the transmission of disease-causing agents are significantly influenced by weather and climate as well, which has an indirect effect on humans (IPCC, 2013). Milder winters and warmer falls and springs may enable the extension of Lyme borreliosis to higher altitudes and latitudes, predominantly in the north of Europe (Semenza and Menne, 2009). Thus, the level of influence depends on the kind of vector (Confalonieri et al., 2007; Kurane, 2010).
Diagnosis
Lyme disease, and especially LE, can be very challenging to diagnose. The most specific (100%) examination is culture of Borrelia spp. This test provides information on active infection, enables the investigation of the structural, molecular, antigenic, and pathogenic properties of the antigen, and can distinguish live from dead organisms (Reed, 2002; Aguero-Rosenfeld et al., 2005; Murray and Shapiro, 2010). But, there are limitations to this exam. The main limitation is the time needed for the culture to reveal its results (up to 12 weeks for it to be considered negative). Other issues are the low sensitivity of the method in all other than the cutaneous manifestation of the disease, its inapplicability for diagnosis in antibiotic-treated patients, the need for special media, and its expense (Karlsson et al., 1990; Nadelman et al., 1990).
Serological examination is widely used and is available in the clinical setting. Frequently used assays are enzyme-linked immunosorbent assay (ELISA), immunofluorescence assays, and Western blotting (Tugwell, 1997; Schutzer et al., 2018), but false-negative and false-positive results may occur (Schutzer et al., 2018). ELISA is recommended as the initial serological examination. Tests are objective, fast, and easy to perform and are suitable for the diagnosis of other forms of LD beside cutaneous. This is the reason why, in the United States, a two-step protocol for the evaluation of B. burgdorferi antibodies in sera has been recommended (Miller et al., 2018). In both ELISA and Immunoblot assays, the antigens used should detect both IgM and IgG antibodies. Immunoblot should have a high specificity of at least 95% (Miller et al., 2018; Schutzer et al., 2018). In the early stages of the disease, serological tests may reveal false-negative results in a high percentage. False-positive results can be seen in mononucleosis, autoimmune states and Treponema pallidum infection. Western blot is more sensitive and specific than ELISA, and it is recommended as a second step in diagnosis and for confirmation of ELISA findings (Miller et al., 2018).
Polymerase Chain Reaction can be very helpful, since it detects the genetic material of Borreliae sp. directly in multiple tissues and provides molecular identification and antimicrobial therapy does not affect the results (Rijpkema et al., 1997). Transvenous endomyocardial biopsy can be indicative of LD. The band-like infiltrate is strongly suggestive, and it can be seen even if the quality of the specimen is limited (Marques, 2015). Its intrinsic limitations, which include sampling error, the necessity that the patient undergo an invasive procedure to obtain appropriate tissue, and the variability of interpretation, restrain its use in clinical practice (Reed, 2002; Aguero-Rosenfeld et al., 2005).
Treatment
Antibiotic therapy in the early stages of LD prevents or attenuates later complications of the disease (Sangha et al., 1998). Antibiotic regimens for the treatment of LD include amoxicillin 500 mg orally three or four times daily for 30 days, doxycycline 100 mg orally twice daily for 30 days, and ceftriaxone 2 g intravenously daily for 2 to 4 weeks (Fish et al., 2008). Cefotaxime 3 g intravenously twice daily for 2 to 4 weeks is reportedly as effective as ceftriaxone in patients who have other late manifestations of LD (50, 51). Patients who have minor cardiac involvement (e.g., prolongation of the PR interval of no more than 0.30 s) and no other symptoms should receive oral antibiotic therapy with amoxicillin or doxycycline as for early disease. Patients who have more severe LC, should be admitted to hospital and administered intravenous ceftriaxone or high-dose penicillin G. As has been mentioned, complete heart block generally resolves within 1 week, with resolution of lesser conduction disturbances within 6 weeks (Olson et al., 1986; McAlister et al., 1989; Fish et al., 2008). A summary of LE treatment from limited cases in the literature is given in Table 1.
Summary and Conclusion
Lyme endocarditis is an extremely rare manifestation of LD. The clinical manifestations of LE are non-specific, and it can be a very challenging diagnosis to make when it is the only manifestation of the disease. Until now, only a few cases have been reported. In case of endocarditis of unknown origin, PCR on heart valve samples is recommended. Physicians should keep in mind the possibility of a borrelial etiology of endocarditis in endemic areas. An appropriate valve tissue sample should be sent for histopathology, culture, and PCR when a cardiac surgeon suspects infective endocarditis during an operation. The use of PCR is crucial to detect and identify the causative organism in infective endocarditis, especially in those with negative blood and tissue cultures. With more frequent PCR, Borrelia sp. may be increasingly found to be the cause of infective endocarditis. Prompt diagnosis and treatment of LE and LC may allow surgical treatment and pacemaker implantation to be avoided. Due to climate change and global warming, LD is a growing problem, and, due to the rising number of LD cases, we can expect a rising number of LE cases as well.
Author Contributions
AN, DB, and MB conceptualized this manuscript, collected the data, and drafted the first manuscript. BP and SR revised final revision of the manuscript. All authors provided critical feedback and contributed to the manuscript.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Adams, D., Fullerton, K., Jajosky, R., Sharp, P., Onweh, D., Schley, A., et al. (2015). Summary of notifiable infectious diseases and conditions – United States, 2013. MMWR Morb. Mortal. Wkly. Rep. 62, 1–122. doi: 10.15585/mmwr.mm6253a1
Aguero-Rosenfeld, M., Wang, G., Schwartz, I., and Wormser, G. (2005). Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev. 18, 484–509. doi: 10.1128/cmr.18.3.484-509.2005
Bacon, R. M., Kugeler, K. J., and Mead, P. S. (2008). Surveillance for Lyme disease-United States, 1992-2006. MMWR Surveill. Summ. 57, 1–9.
Canver, C. C., Chanda, J., DeBellis, D. M., and Kelley, J. M. (2000). Possible relationship between degenerative cardiac valvular pathology and Lyme disease. Ann. Thorac. Surg. 70, 283–285. doi: 10.1016/s0003-4975(00)01452-1
Centers for Disease Control and Prevention [CDC] (2018). Lyme Disease: Data and Surveillance. Available online at: http://www.cdc.gov/lyme/stats/index.html?s_cid=cs_281 (accessed October, 2019).
Confalonieri, U., Menne, B., and Akhtar, P. (2007). “Human health. Climate change: impacts, adaptation and vulnerability,” in Contribution of Working Group II to the Fourth Assessment Report of the Intergovernmental Panel on Climate Change, eds M. L. Parry, O. F. Canziani, and J. P. Palutikof (Cambridge: Cambridge University Press), 391–431.
Dehhaghi, M., Kazemi Shariat, Panahi, H., Holmes, E., Hudson, B., Schloeffel, R., and Guillemin, G. (2019). Human tick-borne diseases in Australia. Front. Cell. Infect. Microbiol. 9:3. doi: 10.3389/fcimb.2019.00003
Estrada-Peña, A., Cutler, S., Potkonjak, A., Vassier-Tussaut, M., Van Bortel, W., Zeller, H., et al. (2018). An updated meta-analysis of the distribution and prevalence of Borrelia burgdorferi s.l. in ticks in Europe. Int. J. Health Geogr. 17:41. doi: 10.1186/s12942-018-0163-7
Fish, A., Pride, Y., and Pinto, D. (2008). Lyme carditis. Infect. Dis. Clin. North Am. 22, 275–288. doi: 10.1016/j.idc.2007.12.008
Froude, J., Gibofsky, A., Buskirk, D. R., Khanna, A., and Zabriskie, J. B. (1989). Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity. Curr. Top. Microbiol. Immunol. 145, 5–26. doi: 10.1007/978-3-642-74594-2_2
Grzesik, P., Oczko-Grzesik, B., and Kepa, L. (2004). Borrelia burgdorferi pathogenesis and the immune response. Przegl. Epidemiol. 58, 589–596.
Haddad, O., Gillinov, M., Fraser, T., Shrestha, N., and Pettersson, G. (2019). Mitral valve endocarditis: a rare manifestation of Lyme disease. Ann. Thorac. Surg. 108, e85–e86. doi: 10.1016/j.athoracsur.2018.12.046
Heinz, F., Stiasny, K., Holzmann, H., Kundi, M., Sixl, W., Wenk, M., et al. (2015). Emergence of tick-borne encephalitis in new endemic areas in Austria: 42 years of surveillance. Euro Surveill. 20, 9–16. doi: 10.2807/1560-7917.es2015.20.13.21077
Hidri, N., Barraud, O., de Martino, S., Garnier, F., Paraf, F., Martin, C., et al. (2012). Lyme endocarditis. Clin. Microbiol. Infect. 18, E531–E532. doi: 10.1111/1469-0691.12016
IPCC, (2013).“Summary for policymakers,” in Climate Change 2013: The Physical Science Basis. Contribution of Working Group I to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change, eds T. F. Stocker, D. Qin, G.-K. Plattner, M. Tignor, S. K. Allen, J. Boschung, et al. (Cambridge: Cambridge University Press).
Jaenson, T. G. T., and Lindgren, E. (2011). The range of Ixodes ricinus and therisk of contracting Lyme borreliosis will increase northwards when the vegetation period becomes longer. Ticks Tick Borne Dis. 2, 44–49. doi: 10.1016/j.ttbdis.2010.10.006
Kameda, G., Vieker, S., Hartmann, J., Niehues, T., and Längler, A. (2012). Diastolic heart murmur, nocturnal back pain, and lumbar rigidity in a 7-year girl: an unusual manifestation of Lyme disease in childhood. Case Rep. 2012:976961. doi: 10.1155/2012/976961
Kannangara, D., Sidra, S., and Pritiben, P. (2019). First case report of inducible heart block in Lyme disease and an update of Lyme carditis. BMC Infect. Dis. 19:428. doi: 10.1186/s12879-019-4025-0
Karlsson, M., Hovind-Hougen, K., Svenungsson, B., and Stiernstedt, G. (1990). Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J. Clin. Microbiol. 28, 473–479. doi: 10.1128/jcm.28.3.473-479.1990
Kostić, T., Momèilović, S., Perišić, Z., Apostolović, S., Cvetković, J., Jovanović, A., et al. (2017). Manifestations of Lyme carditis. Int. J. Cardiol. 232, 24–32. doi: 10.1016/j.ijcard.2016.12.169
Kuhn, K., Campbell-Lendrum, D., Haines, A., and Cox, J. (2005). Using Climate to Predict Infectious Disease Epidemics. Geneva: World Health Organization.
Kurane, I. (2010). The effect of global warming on infectious diseases. Osong Public Health Res. Perspect. 1, 4–9. doi: 10.1016/j.phrp.2010.12.004
Liang, L., and Gong, P. (2017). Climate change and human infectious diseases: a synthesis of research findings from global and spatio-temporal perspectives. Environ. Int. 103, 99–108. doi: 10.1016/j.envint.2017.03.011
Lindgren, E., and Jaenson, T. G. T. (2006). Lyme Borreliosis in Europe: Influences of Climate and Climate Change, Epidemiology, Ecology and Adaptation Measures. Copenhagen: WHO Regional Office for Europe.
Marques, A. (2015). Laboratory diagnosis of Lyme disease. Infect. Dis. Clin. North Am. 29, 295–307. doi: 10.1016/j.idc.2015.02.005
McAlister, H. F., Klementowicz, P. T., Andrews, C., Fisher, J. D., Feld, M., Furman, S., et al. (1989). Lyme carditis: an important cause of reversible heart block. Ann. Intern. Med. 110, 339–345.
Miller, J., Binnicker, M., Campbell, S., Carroll, K., Chapin, K., Gilligan, P., et al. (2018). A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the infectious diseases society of America and the American Society for Microbiologya. Clin. Infect. Dis. 67, e1–e94. doi: 10.1093/cid/ciy381
Murray, T., and Shapiro, E. (2010). Lyme disease. Clin. Lab. Med. 30, 311–328. doi: 10.1016/j.cll.2010.01.003
Nadelman, R., Pavia, C., Magnarelli, L., and Wormser, G. (1990). Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease. Am. J. Med. 88, 21–26. doi: 10.1016/0002-9343(90)90122-t
Olson, L. J., Okafor, E. C., and Clements, I. P. (1986). Cardiac involvement in Lyme disease: manifestations and management. Mayo Clin. Proc. 61, 745–749. doi: 10.1016/s0025-6196(12)62775-x
Paim, A., Baddour, L., Pritt, B., Schuetz, A., and Wilson, J. (2018). Lyme endocarditis. Am. J. Med. 131, 1126–1129. doi: 10.1016/j.amjmed.2018.02.032
Palecek, T., Kuchynka, P., Hulinska, D., Schramlova, J., Hrbackova, H., Vitkova, I., et al. (2010). Presence of Borrelia burgdorferi in endomyocardial biopsies in patients with new-onset unexplained dilated cardiomyopathy. Med. Microbiol. Immunol. 199, 139–143. doi: 10.1007/s00430-009-0141-146
Patel, L., and Schachne, J. (2017). Lyme carditis: a case involving the conduction system and mitral valve. R. I. Med. J. (2013) 100, 17–20.
Petzke, M., and Schwartz, I. (2015). Borrelia burgdorferi pathogenesis and the immune response. Clin. Lab. Med. 35, 745–764. doi: 10.1016/j.cll.2015.07.004
Raveche, E., Schutzer, S., Fernandes, H., Bateman, H., McCarthy, B., Nickell, S., et al. (2005). Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis. J. Clin. Microbiol. 43, 850–856. doi: 10.1128/jcm.43.2.850-856.2005
Reed, K. (2002). Laboratory testing for Lyme disease: possibilities and practicalities. J. Clin. Microbiol. 40, 319–324. doi: 10.1128/jcm.40.2.319-324.2002
Rijpkema, S., Tazelaar, D., Molkenboer, M., Noordhoek, G., Plantinga, G., Schouls, L., et al. (1997). Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronica atrophicans. Clin. Microbiol. Infect. 3, 109–116. doi: 10.1111/j.1469-0691.1997.tb00259
Rudenko, N., Golovchenko, M., Mokracek, A., Piskunova, N., Ruzek, D., Mallatova, N., et al. (2008). Detection of Borrelia bissettii in cardiac valve tissue of a patient with endocarditis and aortic valve stenosis in the Czech Republic. J. Clin. Microbiol. 46, 3540–3543. doi: 10.1128/jcm.01032-08
Sangha, O., Phillips, C. B., and Fleischmann, K. E. (1998). Lack of cardiac manifestations among patients with previously treated Lyme disease. Ann. Intern. Med. 128, 346–353.
Schutzer, S., Body, B., Boyle, J., Branson, B., Dattwyler, R., Fikrig, E., et al. (2018). Direct diagnostic tests for Lyme disease. Clin. Infect. Dis. 68, 1052–1057. doi: 10.1093/cid/ciy614
Semenza, J., and Suk, J. (2017). Vector-borne diseases and climate change: a European perspective. FEMS Microbiol. Lett. 365:fnx244. doi: 10.1093/femsle/fnx244
Semenza, J. C., and Menne, B. (2009). Climate change and infectious diseases in Europe. Lancet Infect. Dis. 9, 365–375. doi: 10.1016/S1473-3099(09)70104-5
Smith, R., and Takkinen, J. (2006). Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Euro Surveill. 11:E060622.1. doi: 10.2807/esw.11.25.02977-en
Steere, A. C., Gross, D., Meyer, A. L., and Huber, B. T. (2001). Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J. Autoimmun. 16, 263–268. doi: 10.1006/jaut.2000.0495
Tian, H. Y., Zhou, S., Dong, L., Van Boeckel, T. P., Cui, Y. J., Wu, Y., et al. (2015). Avian influenza H5N1 viral and bird migration networks in Asia. Proc. Natl. Acad. Sci. U.S.A. 112, 172–177. doi: 10.1073/pnas.1405216112
Tugwell, P. (1997). Laboratory evaluation in the diagnosis of Lyme disease. Ann. Intern. Med. 127, 1109–1123. doi: 10.7326/0003-4819-127-12-199712150-00011
Wasiluk, A., Zalewska-Szajda, B., Waszkiewicz, N., Kȩpka, A., Szajda, D. S., Wojewódzka-Żeleźniakowicz, M., et al. (2011). Lyme disease: etiology, pathogenesis, clinical courses, diagnostics and treatment. Prog. Health Sci. 1, 179–186.
Watts, N., Adger, W. N., Agnolucci, P., and Costello, A. (2015). Health and climate change: policy responses to protect public health. Lancet 386, 1861–1914.
Zajkowska, J., and Hermanowska–Szpakowicz, T. (2002). New aspects of the pathogenesis of Lyme disease. Przegl. Epidemiol. 56(Suppl. 1), 57–67.
Keywords: Lyme disease, Lyme endocarditis, PCR, Borrelia spp., valve involvement
Citation: Nikolić A, Boljević D, Bojić M, Veljković S, Vuković D, Paglietti B, Micić J and Rubino S (2020) Lyme Endocarditis as an Emerging Infectious Disease: A Review of the Literature. Front. Microbiol. 11:278. doi: 10.3389/fmicb.2020.00278
Received: 27 October 2019; Accepted: 06 February 2020;
Published: 26 February 2020.
Edited by:
David Ong, Franciscus Gasthuis & Vlietland, NetherlandsReviewed by:
Marina Pekmezovic, Leibniz Institute for Natural Product Research and Infection Biology, GermanyMuge Cevik, University of St Andrews, United Kingdom
Copyright © 2020 Nikolić, Boljević, Bojić, Veljković, Vuković, Paglietti, Micić and Rubino. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Darko Boljević, darkoboljevic@gmail.com